GEN Exclusives

More »

GEN News Highlights

More »
Sep 26, 2006

Leader Ventures Closes $300-M Fund

  • Leader Ventures launched a fund to provide $300 million in debt and equity to private and public companies. Leader primarily invests in venture-backed companies, including those in the life sciences sectors.

    “We are delighted to be investors in Leader's new fund,” says Richard Harris, manager of M.A.R.S. Lattner, LP, an Atlanta-based family office. “With a solid track record and over 37 years of investing and lending experience, the Leader team has proven their ability to meet the needs of growing companies and deliver top-quartile returns to investors.”



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?